Loading...

Home
ETF
SLS

SLS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SLS News

Investors Focus on Middle East Developments and Job Data

4d agostocktwits

Merck's Acquisition Sparks Interest in Blood Cancer Drug Market

4d agostocktwits

SLS Shares Surge Following Merck's Tern Acquisition, Fueling Buyout Speculation in Blood Cancer Sector: Retail Investors Eye Major Pharma Contender

5d agostocktwits

SLS vs. TERN: Which Pharmaceutical Stock Offers Greater Potential as Merck Plans $6B Investment in Cancer Ahead of Keytruda Patent Expiration?

6d agostocktwits

Sellas Life Sciences Shows Significant Clinical Progress

Mar 20 2026stocktwits

SELLAS Life Sciences Reports 2025 Financials and Clinical Updates

Mar 20 2026NASDAQ.COM

Sellas Life Sciences Narrows FY25 Net Loss Amid Promising Trials

Mar 20 2026stocktwits

SELLAS Life Sciences FY 2025 Earnings Beat Expectations

Mar 19 2026seekingalpha

Sellas Life Sciences Highlights Promising Data for AML Drug SLS009 Ahead of AACR 2026

Mar 18 2026stocktwits

SELLAS Initiates Phase 2 Trial for SLS009 in AML

Mar 12 2026stocktwits

Sellas' Immunotherapy Trial Approaches Key Milestone

Mar 10 2026stocktwits

Wall Street Rebounds Amid Oil Price Volatility

Mar 10 2026stocktwits

Sellas Immunotherapy Advances with Galinpepimut-S

Mar 09 2026stocktwits

Sellas Life Sciences Stock Volatility Amid AML Summit Insights

Mar 06 2026stocktwits

Sellas Life Sciences Stock Soars Ahead of Key AML Trial Data

Mar 05 2026stocktwits

SELLAS Life Sciences Stock Surges Over 200% Amid Positive Trial Data

Mar 04 2026Benzinga